Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA

被引:52
|
作者
Hrast, Martina [1 ]
Rozman, Kaja [1 ]
Jukic, Marko [1 ]
Patin, Delphine [2 ]
Gobec, Stanislav [1 ]
Sova, Matej [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Askerceva 7, SI-1000 Ljubljana, Slovenia
[2] Univ Paris Saclay, Univ Paris Sud, Bacterial Cell Envelopes & Antibiot Grp, I2BC,CEA,CNRS, F-91198 Gif Sur Yvette, France
关键词
Peptidoglycan; MurA enzyme; Antibacterial agents; Quinazolinones; PEPTIDOGLYCAN BIOSYNTHESIS; DISCOVERY; DOCKING;
D O I
10.1016/j.bmcl.2017.05.064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
MurA is an intracellular bacterial enzyme that is essential for peptidoglycan biosynthesis, and is therefore an important target for antibacterial drug discovery. We report the synthesis, in silico studies and extensive structure-activity relationships of a series of quinazolinone-based inhibitors of MurA from Escherichia coli. 3-Benzyloxyphenylquinazolinones showed promising inhibitory potencies against MurA, in the low micromolar range, with an IC50 of 8 mu M for the most potent derivative (58). Furthermore, furan-substituted quinazolinones (38, 46) showed promising antibacterial activities, with MICs from 1 mu g/mL to 8 mu g/mL, concomitant with their MurA inhibitory potencies. These data represent an important step towards the development of novel antimicrobial agents to combat increasing bacterial resistance. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3529 / 3533
页数:5
相关论文
共 50 条
  • [31] Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure
    Dohle, Wolfgang
    Jourdan, Fabrice L.
    Menchon, Gregory
    Prota, Andrea E.
    Foster, Paul A.
    Mannion, Pascoe
    Hamel, Ernest
    Thomas, Mark P.
    Kasprzyk, Philip G.
    Ferrandis, Eric
    Steinmetz, Michel O.
    Leese, Mathew P.
    Potter, Barry V. L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 1031 - 1044
  • [32] Synthesis and structure-activity relationship of inhibitors of protein kinase D
    Rosenker, Kara M. George
    Bravo-Altamirano, Karla
    Frantz, Marie-Celine
    LaValle, Courtney R.
    Tandon, Manuj
    Wang, Q. Jane
    Wipf, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [33] Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors
    Rocha, Debora A.
    Silva, Elany B.
    Fortes, Isadora S.
    Lopes, Marcela S.
    Ferreira, Rafaela S.
    Andrade, Saulo F.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 1426 - 1459
  • [34] The synthesis and structure-activity relationship of pyridazinones as glucan synthase inhibitors
    Ting, Pauline C.
    Kuang, Rongze
    Wu, Heping
    Aslanian, Robert G.
    Cao, Jianhua
    Kim, David W.
    Lee, Joe F.
    Schwerdt, John
    Zhou, Gang
    Wainhaus, Samuel
    Black, Todd A.
    Cacciapuoti, Anthony
    McNicholas, Paul M.
    Xu, Yiming
    Walker, Scott S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1819 - 1822
  • [35] Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline γ-secretase inhibitors
    Truong, Anh P.
    Aubele, Danielle L.
    Probst, Gary D.
    Neitzel, Martin L.
    Semko, Chris M.
    Bowers, Simeon
    Dressen, Darren
    Hom, Roy K.
    Konradi, Andrei W.
    Sham, Hing L.
    Garofalo, Albert W.
    Keim, Pamela S.
    Wu, Jing
    Dappen, Michael S.
    Wong, Karina
    Goldbach, Erich
    Quinn, Kevin P.
    Sauer, John-Michael
    Brigham, Elizabeth F.
    Wallace, William
    Nguyen, Lan
    Hemphill, Susanna S.
    Bova, Michael P.
    Basi, Guriqbal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (17) : 4920 - 4923
  • [36] Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors
    Yu, Yongshi
    Tang, Qi
    Xu, Zhichao
    Li, Siliang
    Jin, Mengyu
    Zhao, Zixuan
    Dong, Chune
    Wu, Shuwen
    Zhou, Hai-Bing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 159 : 206 - 216
  • [37] Synthesis of the novel analogues of dysidiolide and their structure-activity relationship
    Takahashi, M
    Dodo, K
    Sugimoto, Y
    Aoyagi, Y
    Yamada, Y
    Hashimoto, Y
    Shirai, R
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (22) : 2571 - 2574
  • [38] Structure-Activity Relationship of Nonacidic Quinazolinone Inhibitors of Human Microsomal Prostaglandin Synthase 1 (mPGES 1)
    Roersch, Florian
    La Buscato, Estel.
    Deckmann, Klaus
    Schneider, Gisbert
    Schubert-Zsilavecz, Manfred
    Geisslinger, Gerd
    Proschak, Ewgenij
    Groesch, Sabine
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (08) : 3792 - 3803
  • [39] A focused structure-activity relationship study of psoralen-based immunoproteasome inhibitors
    Schiffrer, Eva Shannon
    Sosic, Izidor
    Sterman, Andrej
    Mravljak, Janez
    Rascan, Irena Mlinaric
    Gobec, Stanislav
    Gobec, Martina
    MEDCHEMCOMM, 2019, 10 (11) : 1958 - 1965
  • [40] Synthesis and in-vitro potency of novel quinazolinone-based vitronectin receptor antagonists.
    Lawson, EC
    Costanzo, MJ
    Hoekstra, WJ
    Kinney, WA
    Luci, DK
    Maryanoff, BE
    Wisnoski, D
    Yabut, SC
    Andrade-Gordon, P
    Kauffman, JA
    Santulli, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U652 - U653